Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination

Autor: Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY

Publikováno v: Clinical Ophthalmology, Vol Volume 15, Pp 583-590 (2021)

Homero Contreras-Salinas,1 Mariana Barajas-Hernández,1 Leopoldo Martín Baiza-Durán,1 Alan Omar Vázquez-Álvarez,2 Manuel Alejandro Bautista-Castro,1 Lourdes Yolotzin Rodríguez-Herrera1 1Pharmacovigilance Department, Laboratorios Sophia, S.A. de

Externí odkaz: https://doaj.org/article/0461246abb8d42d18a83b40487dc3999

Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases.

Autor: Contreras-Salinas H; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Baiza-Durán LM; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Bautista-Castro MA; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Alonso-Rodríguez DR; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Rodríguez-Herrera LY; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2022 Oct 31; Vol. 10 (11). Date of Electronic Publication: 2022 Oct 31.